Skip to contentPedder Simon — Chelsea Therapeutics International, Ltd. insider: 45 transactions · InsiderLensPedder Simon
- Director at Chelsea Therapeutics International, Ltd. · on record since Feb 3, 2006
- Chief Executive Officer at Chelsea Therapeutics International, Ltd. · on record since Feb 3, 2006
- Director at Unite Acquisition 1 Corp. · on record since Feb 18, 2025
- Executive Chairman at Unite Acquisition 1 Corp. · on record since Feb 18, 2025
- 10% owner at Unite Acquisition 1 Corp. · on record since Feb 18, 2025
- Director at Cellectar Biosciences, Inc. · on record since Aug 22, 2014
- President and CEO at Cellectar Biosciences, Inc. · on record since Aug 22, 2014
- Director at OXIGENE INC · on record since Mar 23, 2016
- Director at IVORY CAPITAL CORP · on record since Feb 22, 2005
- Chief Executive Officer at IVORY CAPITAL CORP · on record since Feb 22, 2005
- Director at ADVANCE TECHNOLOGIES INC · on record since May 17, 2018
- See Remarks at Athenex, Inc. · on record since Aug 21, 2018
- Director at DELCATH SYSTEMS INC · on record since Feb 5, 2019
- Executive Chairman of the Bd at ADVANCE TECHNOLOGIES INC · on record since Apr 17, 2019
Insider trading activity of Pedder Simon
- Transactions on record
- 45
- since Feb 3, 2006
- Open-market buys
- 11
- $168.3K
- Open-market sells
- 0
- Companies traded
- 7
- last filing Sep 10, 2025
Figures computed from official regulatory filings — methodology.
Companies where Pedder Simon has traded
- Unite Acquisition 1 Corp.1 tx · Sep 10, 2025
- Athenex, Inc.10 tx · $40.8K · Aug 5, 2021
- ADVANCE TECHNOLOGIES INC13 tx · $108.5K · Apr 13, 2020
- DELCATH SYSTEMS INC1 tx · Feb 5, 2019
- OXIGENE INC4 tx · Jun 22, 2018
- Cellectar Biosciences, Inc.2 tx · $50K · Aug 22, 2014
- Chelsea Therapeutics International, Ltd.14 tx · $27.2K · Jan 27, 2012
Track record of Pedder Simon
Statistical track record
Free- Open-market buys
- 12
- Last buy
- Aug 27, 2019
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Pedder Simon
Co-insiders of Pedder Simon
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Rueckert William DodgeChelsea Therapeutics International, Ltd. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Sep 10, 2025 | AwardD | 192,231 | 0.00 USD | $0 | SEC |
| Aug 5, 2021 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Aug 5, 2021 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Aug 6, 2020 | AwardD | 60,000 | 0.00 USD | $0 | SEC |
| Apr 13, 2020 | Other | -20,901 | 2.57 USD | $53.7K | SEC |
| Aug 29, 2019 | Buy | 6,734 | 2.98 USD | $20.1K | SEC |
| Jul 2, 2019 | AwardD | 117 | 0.00 USD | $0 | SEC |
| May 29, 2019 | AwardD | 300,000 | 0.00 USD | $0 | SEC |
| May 29, 2019 | Award | 250,000 | 0.00 USD | $0 | SEC |
| May 16, 2019 | Buy | 6,000 | 5.06 USD | $30.4K | SEC |
| Apr 17, 2019 | AwardD | 300,000 | 0.00 USD | $0 | SEC |
| Apr 17, 2019 | Award | 1,402 | 0.00 USD | $0 | SEC |
| Apr 1, 2019 | AwardD | 882 | 0.00 USD | $0 | SEC |
| Mar 5, 2019 | AwardD | 60,000 | 0.00 USD | $0 | SEC |
| Mar 4, 2019 | AwardD | 60,000 | 0.00 USD | $0 | SEC |
| Feb 5, 2019 | AwardD | 100,000 | 0.00 USD | $0 | SEC |
| Jan 2, 2019 | AwardD | 1,504 | 0.00 USD | $0 | SEC |
| Nov 14, 2018 | Buy | 2,908 | 10.26 USD | $29.8K | SEC |
| Oct 1, 2018 | AwardD | 990 | 0.00 USD | $0 | SEC |
| Aug 21, 2018 | AwardD | 130,000 | 0.00 USD | $0 | SEC |
| Jul 3, 2018 | AwardD | 1,012 | 4.34 USD | $4.4K | SEC |
| Jun 22, 2018 | AwardD | 258,171 | 0.00 USD | $0 | SEC |
| May 17, 2018 | AwardD | 8,357 | 0.00 USD | $0 | SEC |
| Apr 10, 2018 | AwardD | 16,714 | 0.00 USD | $0 | SEC |
| Jul 28, 2017 | Buy | 1,000 | 11.00 USD | $11K | SEC |